251 related articles for article (PubMed ID: 21604269)
1. Amelioration of type I diabetes-induced osteoporosis by parathyroid hormone is associated with improved osteoblast survival.
Motyl KJ; McCauley LK; McCabe LR
J Cell Physiol; 2012 Apr; 227(4):1326-34. PubMed ID: 21604269
[TBL] [Abstract][Full Text] [Related]
2. Preactivation of β-catenin in osteoblasts improves the osteoanabolic effect of PTH in type 1 diabetic mice.
Chen S; Yang L; He S; Yang J; Liu D; Bao Q; Qin H; Du W; Zhong X; Chen C; Zong Z
J Cell Physiol; 2020 Feb; 235(2):1480-1493. PubMed ID: 31301073
[TBL] [Abstract][Full Text] [Related]
3. Over-expression of TIMP-1 in osteoblasts increases the anabolic response to PTH.
Merciris D; Schiltz C; Legoupil N; Marty-Morieux C; de Vernejoul MC; Geoffroy V
Bone; 2007 Jan; 40(1):75-83. PubMed ID: 16949899
[TBL] [Abstract][Full Text] [Related]
4. Loss of Gsα in the Postnatal Skeleton Leads to Low Bone Mass and a Blunted Response to Anabolic Parathyroid Hormone Therapy.
Sinha P; Aarnisalo P; Chubb R; Poulton IJ; Guo J; Nachtrab G; Kimura T; Swami S; Saeed H; Chen M; Weinstein LS; Schipani E; Sims NA; Kronenberg HM; Wu JY
J Biol Chem; 2016 Jan; 291(4):1631-1642. PubMed ID: 26598522
[TBL] [Abstract][Full Text] [Related]
5. CCAAT/enhancer binding protein β-deficiency enhances type 1 diabetic bone phenotype by increasing marrow adiposity and bone resorption.
Motyl KJ; Raetz M; Tekalur SA; Schwartz RC; McCabe LR
Am J Physiol Regul Integr Comp Physiol; 2011 May; 300(5):R1250-60. PubMed ID: 21346244
[TBL] [Abstract][Full Text] [Related]
6. [Parathyroid and bone. Effect of parathyroid hormone on bone quality].
Ito M
Clin Calcium; 2007 Dec; 17(12):1858-64. PubMed ID: 18057661
[TBL] [Abstract][Full Text] [Related]
7. Disruption of LRP6 in osteoblasts blunts the bone anabolic activity of PTH.
Li C; Xing Q; Yu B; Xie H; Wang W; Shi C; Crane JL; Cao X; Wan M
J Bone Miner Res; 2013 Oct; 28(10):2094-108. PubMed ID: 23609180
[TBL] [Abstract][Full Text] [Related]
8. Intermittent PTH stimulates periosteal bone formation by actions on post-mitotic preosteoblasts.
Jilka RL; O'Brien CA; Ali AA; Roberson PK; Weinstein RS; Manolagas SC
Bone; 2009 Feb; 44(2):275-86. PubMed ID: 19010455
[TBL] [Abstract][Full Text] [Related]
9. Histological Effects of the Combined Administration of Eldecalcitol and a Parathyroid Hormone in the Metaphyseal Trabeculae of Ovariectomized Rats.
Hasegawa T; Yamamoto T; Sakai S; Miyamoto Y; Hongo H; Qiu Z; Abe M; Takeda S; Oda K; de Freitas PHL; Li M; Endo K; Amizuka N
J Histochem Cytochem; 2019 Mar; 67(3):169-184. PubMed ID: 30311820
[TBL] [Abstract][Full Text] [Related]
10. Current perspectives on parathyroid hormone (PTH) and PTH-related protein (PTHrP) as bone anabolic therapies.
Esbrit P; Alcaraz MJ
Biochem Pharmacol; 2013 May; 85(10):1417-23. PubMed ID: 23500550
[TBL] [Abstract][Full Text] [Related]
11. Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice.
Iida-Klein A; Zhou H; Lu SS; Levine LR; Ducayen-Knowles M; Dempster DW; Nieves J; Lindsay R
J Bone Miner Res; 2002 May; 17(5):808-16. PubMed ID: 12009011
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effects of high dietary calcium and exogenous parathyroid hormone in promoting osteoblastic bone formation in mice.
Feng Y; Zhou M; Zhang Q; Liu H; Xu Y; Shu L; Zhang J; Miao D; Ren Y
Br J Nutr; 2015 Mar; 113(6):909-22. PubMed ID: 25744000
[TBL] [Abstract][Full Text] [Related]
13. Parathyroid hormone temporal effects on bone formation and resorption.
Kroll MH
Bull Math Biol; 2000 Jan; 62(1):163-88. PubMed ID: 10824426
[TBL] [Abstract][Full Text] [Related]
14. Sustained RANKL response to parathyroid hormone in oncostatin M receptor-deficient osteoblasts converts anabolic treatment to a catabolic effect in vivo.
Walker EC; Poulton IJ; McGregor NE; Ho PW; Allan EH; Quach JM; Martin TJ; Sims NA
J Bone Miner Res; 2012 Apr; 27(4):902-12. PubMed ID: 22190112
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor I is required for the anabolic actions of parathyroid hormone on mouse bone.
Bikle DD; Sakata T; Leary C; Elalieh H; Ginzinger D; Rosen CJ; Beamer W; Majumdar S; Halloran BP
J Bone Miner Res; 2002 Sep; 17(9):1570-8. PubMed ID: 12211426
[TBL] [Abstract][Full Text] [Related]
16. [Morphological analysis of bone dynamics and metabolic bone disease. Effects of parathyroid hormone on bone tissue].
Miyakoshi N
Clin Calcium; 2011 Apr; 21(4):575-81. PubMed ID: 21447925
[TBL] [Abstract][Full Text] [Related]
17. Short-term intermittent PTH 1-34 administration enhances bone formation in SCID/Beige mice.
Sheehan S; Muthusamy A; Paul E; Sikes RA; Gomes RR
Endocr J; 2010; 57(5):373-82. PubMed ID: 20139633
[TBL] [Abstract][Full Text] [Related]
18. Differential transcriptional effects of PTH and estrogen during anabolic bone formation.
von Stechow D; Zurakowski D; Pettit AR; Müller R; Gronowicz G; Chorev M; Otu H; Libermann T; Alexander JM
J Cell Biochem; 2004 Oct; 93(3):476-90. PubMed ID: 15372627
[TBL] [Abstract][Full Text] [Related]
19. Effect of treatment for 6 months with human parathyroid hormone (1-34) peptide in ovariectomized cynomolgus monkeys (Macaca fascicularis).
Jerome CP; Johnson CS; Vafai HT; Kaplan KC; Bailey J; Capwell B; Fraser F; Hansen L; Ramsay H; Shadoan M; Lees CJ; Thomsen JS; Mosekilde L
Bone; 1999 Sep; 25(3):301-9. PubMed ID: 10495134
[TBL] [Abstract][Full Text] [Related]
20. Intermittent parathyroid hormone therapy to increase bone formation.
Thomas T
Joint Bone Spine; 2006 May; 73(3):262-9. PubMed ID: 16563840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
